Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells - Bosch, J J; Iheagwara, U K; Reid, S (Cancer Immunol Immunother, 2010)